Cargando…

Pharmacological trials for long COVID: first light at the end of the tunnel

Detalles Bibliográficos
Autor principal: Buonsenso, Danilo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647474/
https://www.ncbi.nlm.nih.gov/pubmed/36407125
http://dx.doi.org/10.1016/j.lanepe.2022.100544
_version_ 1784827391176081408
author Buonsenso, Danilo
author_facet Buonsenso, Danilo
author_sort Buonsenso, Danilo
collection PubMed
description
format Online
Article
Text
id pubmed-9647474
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-96474742022-11-14 Pharmacological trials for long COVID: first light at the end of the tunnel Buonsenso, Danilo Lancet Reg Health Eur Comment Elsevier 2022-11-10 /pmc/articles/PMC9647474/ /pubmed/36407125 http://dx.doi.org/10.1016/j.lanepe.2022.100544 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Comment
Buonsenso, Danilo
Pharmacological trials for long COVID: first light at the end of the tunnel
title Pharmacological trials for long COVID: first light at the end of the tunnel
title_full Pharmacological trials for long COVID: first light at the end of the tunnel
title_fullStr Pharmacological trials for long COVID: first light at the end of the tunnel
title_full_unstemmed Pharmacological trials for long COVID: first light at the end of the tunnel
title_short Pharmacological trials for long COVID: first light at the end of the tunnel
title_sort pharmacological trials for long covid: first light at the end of the tunnel
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647474/
https://www.ncbi.nlm.nih.gov/pubmed/36407125
http://dx.doi.org/10.1016/j.lanepe.2022.100544
work_keys_str_mv AT buonsensodanilo pharmacologicaltrialsforlongcovidfirstlightattheendofthetunnel